Citi Pharma gets FDA nod to start exporting nutraceuticals to the United States
The pharmaceutical ingredients manufacturer enters the consumer-facing market in the US with a product the US regulator classifies as food, and not drugs
Citi Pharma completes first export to MENA region, targets EUR 10 million in annual global sales
Finalizes EUR 560,000 shipment; aims to expand exports to North America and beyond
DRAP to establish ‘Code of Ethics’ for doctors and pharma companies
Karachi: Drug Regulation Authority of Pakistan (DRAP) is planning to establish a much needed ‘Code of Ethics’ for doctors and pharmaceutical companies,...
Ferozsons launches biologic to treat diabetes
Pharmaceutical company’s biotech subsidiary to launch the new product in one of Pakistan’s biggest therapeutic areas
Govt decision to increase medicine prices augurs well for domestic drugmakers: Fitch Solutions
Revenue generating opportunities for local pharmaceutical companies in Pakistan will improve following the decision by the government to increase the prices of medicines, said Fitch Solutions
IPO proceeds in 2018 plunged by 49% to Rs4.8 billion
AGP Pharmaceutical, one of the largest companies in the country’s pharmaceutical sector via its offer for sale (OFS) collected 65% of total raised capital during 2018
Searle to sell its entire shareholding in Pakistani subsidiary
Board approves sale of 90.61% stake to IJARA-led consortium
UK report claims Pakistan’s Covid-19 medicine enough for national demand
Pakistan, along with India, is the only one among developing countries to have effectively stored enough of Remdesivir to meet their national...
Is Treet Corporation Pakistan’s next big conglomerate?
Syed Sheharyar Ali is now the fourth generation of his family to be a major business owner in the region that is...
BF Biosciences expands production, launches diabetes treatment, secures listing approval
Company receives approval for brownfield expansion and launches Sematide, a new diabetes treatment, while listing application is greenlit by SECP and PSX
AGP acquires portfolio of products from American pharma firm Viatris
AGP claims newly acquired products will add Rs20b to annual revenues
Pharma sector earnings rise 3.1x to Rs24.8bn in 2024, driven by 15% rise in net sales
Net sales reach Rs318bn, gross margins improve to 36%, while finance costs rise to Rs8bn in 2024; deregulation of drug prices boosts profitability.
Ferozsons dissociates itself from marketing of unlicensed Covid-19 treatment imported from Bangladesh
Ferozsons Laboratories Limited has dissociated itself from the launch of an unlicensed treatment for Covid-19, being imported from Bangladesh.
Clarifying its position, the...
Britain nears 500 million pound deal for Sanofi, GSK Covid-19 vaccine
LONDON: Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline (GSK) for 60 million...
OBS Pakistan amalgamates AGP with AitkenStuart
It is pertinent to mention that rumours had been circulating that OBS Pakistan was going through major restructuring and this acquisition by Searle comes as a surprise for the market.